|
Post by spiro on Jul 14, 2014 6:42:04 GMT -5
|
|
|
Post by jefferson on Jul 14, 2014 7:24:46 GMT -5
can't find anything else confirming this... I hope its true!
|
|
|
Post by liane on Jul 14, 2014 7:40:15 GMT -5
I also see nothing on MNKD's SEC filings page.
|
|
|
Post by spiro on Jul 14, 2014 7:41:42 GMT -5
Who knows? At least it' gives something new to think about. There is also an Allergan rumor out there.
|
|
|
Post by brentie on Jul 14, 2014 8:57:46 GMT -5
Who knows? At least it' gives something new to think about. There is also an Allergan rumor out there. Biotech Stocks to Watch AbbVie and MannKind: Shares of MannKind Corp. have now dropped nearly 7% since announcing the approval of its inhaled insulin product Afrezza by the Food and Drug Administration. The shares have hardly recovered since, as investors begin to take profits following the recent run-up heading into the approval. AbbVie and MannKind MannKind’s next catalyst is likely to be a partnership.The details of the widely anticipated commercialization partnership between Allergan and MannKind should ultimately dictate how this stock performs over the long term. And right now, only speculation can be done about the future of this partnership. www.technews.org/biotech-stocks-stocks-to-watch-abbvie-and-mannkind/2910146/
|
|
|
Post by bradleysbest on Jul 14, 2014 9:05:49 GMT -5
If true is AGN the company to take Afrezza & MNKD to the next level?
|
|
|
Post by brentie on Jul 14, 2014 9:08:29 GMT -5
|
|
|
Post by bradleysbest on Jul 14, 2014 9:38:32 GMT -5
Maybe this is a tactic to get the "big" BP to ante up .....
|
|
|
Post by ashiwi on Jul 14, 2014 10:01:23 GMT -5
The one good thing about Allergan is that the 4 years I have been following MNKD have given me my share of wrinkles. Allergan's line of cosmetic products and dermatological products just might be the answer.
|
|
|
Post by babaoriley on Jul 14, 2014 10:48:37 GMT -5
Well, ashiwi, that brings me back to GSK.... the maker of TUMS.
|
|
|
Post by BD on Jul 14, 2014 11:03:32 GMT -5
And of course TEVA (they bought out NuPathe...developers of a migraine treatment )
|
|
|
Post by thsloppy on Jul 16, 2014 15:26:48 GMT -5
Made a little money on that one didn't we BD! If the stock continues to pull back as time moves on I'm going to pick up a few more shares. I've sold about 60% of my position after a double but much of the risk is now removed (financing has me a little concerned but hopefully will not need it).
|
|
|
Post by BD on Jul 16, 2014 19:09:59 GMT -5
sloppy, that was definitely the shortest time between my taking an initial position in something and having it get bought out! I can actually thank my migraines for something, lol
|
|